These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22259181)
1. Phosphorylated p120-catenin expression has predictive value for oral cancer progression. Ma LW; Zhou ZT; He QB; Jiang WW J Clin Pathol; 2012 Apr; 65(4):315-9. PubMed ID: 22259181 [TBL] [Abstract][Full Text] [Related]
2. Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions. Ma LW; Zhou ZT; He QB; Jiang WW J Oral Pathol Med; 2013 Jan; 42(1):47-52. PubMed ID: 22671975 [TBL] [Abstract][Full Text] [Related]
3. Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complex. Li YY; Zhou CX; Gao Y Oral Oncol; 2015 Oct; 51(10):935-43. PubMed ID: 26194050 [TBL] [Abstract][Full Text] [Related]
4. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma. Sun L; Feng J; Ma L; Liu W; Zhou Z Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820 [TBL] [Abstract][Full Text] [Related]
5. Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma. Jiang Y; Liao L; Shrestha C; Ji S; Chen Y; Peng J; Wang L; Liao E; Xie Z Int J Clin Exp Pathol; 2015; 8(8):9042-51. PubMed ID: 26464646 [TBL] [Abstract][Full Text] [Related]
6. beta- and gamma-catenin expression in oral dysplasia. Lo Muzio L; Lo Russo L; Falaschini S; Ciavarella D; Pentenero M; Arduino P; Favia G; Maiorano E; Rubini C; Pieramici T; Gandolfo S Oral Oncol; 2009 Jun; 45(6):501-4. PubMed ID: 18715817 [TBL] [Abstract][Full Text] [Related]
7. Is expression of p120ctn in oral squamous cell carcinomas a prognostic factor? Lo Muzio L; Pannone G; Santarelli A; Bambini F; Mascitti M; Rubini C; Testa NF; Dioguardi M; Leuci S; Bascones A; Reynolds AB; Mariggiò MA Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):789-98. PubMed ID: 23706919 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. Kaur J; Sawhney M; DattaGupta S; Shukla NK; Srivastava A; Walfish PG; Ralhan R PLoS One; 2013; 8(6):e67361. PubMed ID: 23840677 [TBL] [Abstract][Full Text] [Related]
9. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance. Prgomet Z; Andersson T; Lindberg P Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941 [TBL] [Abstract][Full Text] [Related]
10. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701 [TBL] [Abstract][Full Text] [Related]
11. p120-Catenin Is Required for Dietary Calcium Suppression of Oral Carcinogenesis in Mice. Xie Z; Yuan Y; Jiang Y; Shrestha C; Chen Y; Liao L; Ji S; Deng X; Liao E; Bikle DD J Cell Physiol; 2017 Jun; 232(6):1360-1367. PubMed ID: 27682597 [TBL] [Abstract][Full Text] [Related]
12. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis. Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the levels of salivary paxillin in oral potentially malignant disorders and malignant lesions. Hussine AA; Selim K; Shaker O; Kamal Y BMC Oral Health; 2024 Jul; 24(1):834. PubMed ID: 39048985 [TBL] [Abstract][Full Text] [Related]
14. Concomitant loss of p120-catenin and β-catenin membrane expression and oral carcinoma progression with E-cadherin reduction. Sasaya K; Sudo H; Maeda G; Kawashiri S; Imai K PLoS One; 2013; 8(8):e69777. PubMed ID: 23936352 [TBL] [Abstract][Full Text] [Related]
15. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma. Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414 [TBL] [Abstract][Full Text] [Related]
16. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis. Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306 [TBL] [Abstract][Full Text] [Related]
17. Clinical implications of heat shock protein 70 in oral carcinogenesis and prediction of progression and recurrence in oral squamous cell carcinoma patients: a retrospective clinicopathological study. Elhendawy HA Eur J Med Res; 2023 Oct; 28(1):464. PubMed ID: 37884988 [TBL] [Abstract][Full Text] [Related]
18. Ribosomal protein S6 phosphorylation is associated with epithelial dysplasia and squamous cell carcinoma of the oral cavity. Chaisuparat R; Rojanawatsirivej S; Yodsanga S Pathol Oncol Res; 2013 Apr; 19(2):189-93. PubMed ID: 23015458 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity. Nomura H; Uzawa K; Ishigami T; Kouzu Y; Koike H; Ogawara K; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H BMC Cancer; 2008 Feb; 8():39. PubMed ID: 18237446 [TBL] [Abstract][Full Text] [Related]
20. Survivin phosphorylation and M-phase promoting factor in oral carcinogenesis. Pannone G; Bufo P; Serpico R; Rubini C; Zamparese R; Corsi F; Pedicillo MC; Pannone G; Staibano S; De Rosa G; Lo Muzio L Histol Histopathol; 2007 Nov; 22(11):1241-9. PubMed ID: 17647197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]